ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares -7.7% ·
flujo de acciones -3.0% ·
nuevas posiciones netas -8.3%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +2 | 54.24M | $9.34B | +10 | −7 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | — |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | — | 9.47M | $2.97B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.93M | -12.4% | $615.20M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.93M | -12.4% | $615.20M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.11M | -31.4% | $443.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.12M | +574.6% | $234.08M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.12M | +574.6% | $234.08M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (pasivo) | 1.01M | +0.2% | $211.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 856.70K | +649.7% | $179.66M | 0.5% | ▲ Add | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 571.61K | -1.5% | $119.87M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 571.61K | -1.5% | $119.87M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 340.78K | — | $71.46M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 225.63K | -70.9% | $47.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 125.80K | -40.7% | $26.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 88.74K | Nuevo | $18.61M | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 88.74K | Nuevo | $18.61M | 0.0% | New | 1 | SEC ↗ |
| 22 | Geode Capital Management ✦ (pasivo) | 84.34K | +1.1% | $17.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Adage Capital Partners ✦ | 19.68K | Nuevo | $4.13M | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $18.61M | 0.0% |
| Marshall Wace | $18.61M | 0.0% |
| Adage Capital Partners | $4.13M | 0.0% |
Posición cerrada
| Arrowstreet Capital | $16.17M | era 0.0% |
| Fisher Asset Management | $1.58M | era 0.0% |
| Capital World Investors | $380,398 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 414 tenedores, 78.10M acciones, $8.66B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 105 acc. · $17,196
Director · 67 acc. · $11,089
Director · 280 acc. · $45,562
Director · 305 acc. · $49,950
Director · 1.88K acc. · $309,204
Director · 212 acc. · $35,088
Director · 95 acc. · $15,458
Director · 642 acc. · $105,590
Director · 73 acc. · $12,082
Director · 88 acc. · $14,319
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología